Chicago Cubs announce Horizon Therapeutics as new legacy partner – MLB.com

CHICAGO The Chicago Cubs today announced Horizon Therapeutics (Nasdaq: HZNP) as a new Legacy Partner. The long-term partnership includes naming rights to the left field gate located on Waveland Avenue, various in-ballpark signage elements at Sloan Park and Wrigley Field including the prominent left field sign behind the Budweiser Bleachers and static signage behind home plate, as well as a new Cubs STEAM Program, presented by Horizon, created in an effort to inspire more Chicagoland-area middle and high school students to explore opportunities in STEAM (science, technology, engineering, art and math).

The Cubs STEAM Program, presented by Horizon and in partnership with Science of Sport, will provide local students with increased access to STEAM in an effort to inspire todays youth to consider and pursue these fields as future career paths. To build awareness of these fields of study, the program will focus primarily on the science of baseball, where students can explore through real-world examples and hands-on learning the mathematics and science behind baseball-related actions such as launch angles, curveballs and fastballs. The program will launch this fall and will include a citywide science fair where participants will be provided with the opportunity to show off their STEAM skills for a chance to attend a two-week STEAM summer camp.

Were excited to welcome Horizon to the Cubs family as our newest Legacy Partner, said Cubs President of Business Operations Crane Kenney. Horizon shares our commitment to being a good neighbor in the communities where we work and live, so we are thrilled to launch the Cubs STEAM Program to expose Chicagoland youth to future education and career options. By focusing this effort in Chicago, we hope students across this great city take full advantage of this innovative, citywide science camp and fair.

Horizon, which was founded in 2008, is an international biotechnology company with U.S. headquarters in Deerfield, IL, that focuses on researching, developing and commercializing medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. In order to bring awareness to the more than 7,000 known rare diseases, the Cubs and Horizon will host an event next season during Spring Training in recognition of Rare Disease Day.

Horizon started from humble roots in the Chicago-area in 2008 and as we continue to grow, we look for partners like the Cubs to help us continue to make a meaningful impact in the community, said Horizon Chairman, President and Chief Executive Officer Tim Walbert. Together with the Cubs, we have the opportunity to harness the ingenuity of these students, nurture the next generation of science leaders through this unique programming, as well as raise awareness about the significant impact of rare diseases.

Horizon will become the 11th Legacy Partner of the Cubs joining Advocate Health Care, American Airlines, Anheuser-Busch, Beam Suntory, Gallagher, Marriott, Nuveen, Sloan Valve Company, Toyota and Wintrust.

About Horizon: Horizon is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, please visit http://www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.

Original post:

Chicago Cubs announce Horizon Therapeutics as new legacy partner - MLB.com